Ventricular Assist Devices Market Outlook 2025 - Abbott, Abiomed, Berlin Heart, Bivacor, CardiacAssist, Inc., Evaheart, Maquet, Jarvik Heart, Medtronic
Rise in awareness about the technological developments and use of ventricular assist devices in heart failure treatment will primarily drive industry growth in the near future. Growing mortality rates and surge in hospitalizations in the Latin America region due to high prevalence of heart failure will escalate the ventricular assist devices industry expansion. Moreover, lack of heart donors across the globe will serve to be another major market boosting factors. According to NCBI, the number of heart donations is expected to decrease in the near future and heart failure prevalence is estimated to increase multifold. Such factors will increase the demand for ventricular assist devices, thereby fueling the market growth.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1357103/
Ventricular assist devices market is expected to exceed USD 3.5 billion by 2025. Increasing number of heart failure cases across the globe, technological developments in ventricular assist devices and shortage of heart donors will boost ventricular assist devices market growth over the analysis timeframe.
Bridge-to-transplant (BTT) therapy market is estimated to show substantial CAGR of more than 5.5% during the forecast period. As per the American Heart Association (AHA) journal, BTT-VAD therapy is associated with increase in patient?s survival rate and cost-effectiveness of the treatment. Thus, accessibility to such affordable therapies will increase the adoption of these devices in the low- and middle-income countries, thereby fueling business growth during the upcoming years.
Continuous flow ventricular assist devices market is estimated to witness more than 6% growth over the forecast timeframe. Wide usage of these devices in the patients requiring mechanical circulatory support as destination and bridge-to-transplant therapy for end-stage heart failure will favor segment growth. Aforementioned factors are projected to play a significant role in augmenting the industry growth.
The sales of ventricular assist devices in the people aged between 40-59 years of age accounted for over USD 900 million in 2018. Growing prevalence of heart failure among the people between 40-59 years of age will serve as a major factors that will spur ventricular assist devices market over the analysis period.
Some of the leading players in the ventricular assist devices market include Abbott, Abiomed, Berlin Heart, Bivacor, CardiacAssist, Inc., Evaheart, Maquet, Jarvik Heart, Medtronic, Terumo Corporation and others. These companies focus on strategic decisions such as partnerships and collaborations to expand their product portfolio and capitalize on market opportunities. Additionally, inorganic strategies such as mergers and acquisitions help in company?s geographical expansion.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1357103/
U.S. ventricular assist devices market is estimated to show robust CAGR of around 5.0% over the forecast timeframe. As per the American College of Cardiology, around 800,000 people in the U.S. die due to cardiovascular diseases. Growing prevalence of CVD diseases, adoption of sedentary lifestyle, increasing heart failure rate among the population and recent technological advancements are some of the major market driving factors in the country.
Some major findings of the ventricular assist devices market report include:
- Increase in number of people suffering from heart failure and other cardiovascular diseases across the globe will serve to be one of the major impact rendering factors in the ventricular assist devices market growth.
- Adoption of ventricular assist devices is increasing on account of technological advancement in these devices and its widespread application in the treatment of heart failure.
- North America ventricular assist devices market held the maximum revenue share in the year 2018 owing to the factors including presence of major industry players, growing incidence of heart failure, accessibility to state-of-the-art healthcare facilities, favorable reimbursement policies and insurance coverage.
- Companies operating in ventricular assist devices market resort to strategic collaborations, mergers & acquisitions to strengthen their market position.
More Details on this Report At: https://www.marketstudyreport.com/reports/ventricular-assist-devices-market
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
US Toll Free: 1-866-764-2150
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ventricular Assist Devices Market Outlook 2025 - Abbott, Abiomed, Berlin Heart, Bivacor, CardiacAssist, Inc., Evaheart, Maquet, Jarvik Heart, Medtronic here
News-ID: 1975281 • Views: 307
More Releases from marketstudyreport.com
Covid -19 Impact on Video Conferencing Market Size 2026: Top Companies, Trends a …
Market Study Report recently introduced new title on “2020-2026 Global Video Conferencing Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates Market size outlook and status to 2026. Video Conferencing Market size is anticipated to grow at over 19% CAGR between 2020 and 2026. The global video conferencing market is set to register a tremendous rise in its growth
What's driving the Patient Monitoring Devices Market Size? Fukuda, Philips, Skan …
Selbyville, Delaware the prime objective of Patient Monitoring Devices report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report. Wireless segment is anticipated to witness more than 5% growth over the forecast period. Substantial growth can be attributed to rising preference for
What's driving the 3D Implants Market trends? Stryker, Smith and Nephew, DJO Glo …
The 3D Implants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Request a sample Report of 3D Implants Market at: https://www.marketstudyreport.com/request-a-sample/2679238/?utm_source=OPR.com/&utm_medium=SP The most likely (base case) scenario
Artificial Vascular Implants Market is thriving worldwide by 2025 | Top Key Play …
Global Artificial Vascular Implants Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2025. Artificial Vascular Implants Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Artificial Vascular Implants market and provides information regarding the revenue for the period 2020 to 2025. The Artificial Vascular Implants market report provides
More Releases for Ventricular
Latest Evolution of Ventricular Drainage Sets Market Analysis 2026
Ventricular Drainage Sets Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Ventricular Drainage Sets market research report is a professional and in-depth study on the current state of Ventricular Drainage Sets Industry. The Ventricular Drainage Sets Market research report covers the present scenario and
Left Ventricular Dysfunction - Pipeline Review, H1 2018
Left Ventricular Dysfunction Overview Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and Left Ventricular Dysfunction. Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811435-left-ventricular-dysfunction-pipeline-review-h1-2018 Top Companies mentioned Bayer AG Innopharmax Inc Mesoblast Ltd Novartis AG Quantum Genomics SA TiGenix NV Left Ventricular Dysfunction Industry Major Outlook Pharmaceutical and Healthcare latest pipeline guide Left Ventricular Dysfunction -
Ventricular Tachycardia Market Forecast Report Offers Actionable Insights 2017 - …
Ventricular tachycardia is a condition, wherein the pulse rate is more than 100 beats per minute with minimum three continuous irregular heartbeats. This condition occurs in bottom chambers of the heart and develops as an early or late complication of heart attack. Patients suffering from cardiomyopathy, myocarditis, or valvular heart disease are at a higher risk of developing ventricular tachycardia. Major reasons for ventricular tachycardia are changes in pH values,
Left Ventricular Dysfunction - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2017, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape. Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and coronary artery disease. Report Highlights Publisher's Pharmaceutical and Healthcare
Ventricular Tachycardia Treatment Market And Segment Forecasts To 2017 – 2025
Ventricular tachycardia is a life threatening heart condition in which arrhythmic heart beats occur in the ventricles. The two lower chambers of the heart are known as ventricles. They are responsible for supplying the blood received from atria to different parts of the body. When a person suffers from ventricular tachycardia, a high pulse with more than 100 beats per minute is registered with minimum 3 irregular heartbeats experienced in
Ventricular Assist Devices (VAD) Market Assessment
Ventricular assist devices (VAD) are mechanical pumps used to support patients with a weakened heart or in case of heart failure to temporarily maintain heart function. The devices helps in re-establishing normal hemodynamics under conditions involving damaged ventricle. Increasing trend for sedentary lifestyle, rising obesity population globally, lifestyle changes and various other factors have resulted an increase in cardiovascular disorders. This rising prevalence across the globe has been a major